Join the bioprinting event of the year and discover the potential of bioprinting in healthcare applications
The CELLINK Partnership Conference, October 25-27, Portsmouth, UK
The CELLINK Partnership Conference, October 25-27, Portsmouth, UK
The custom monoclonal antibody reveals potential HER2+ breast cancer target
The collaborative partnership aims to communicate the latest advances in pharmaceutical science to accelerate the field and improve global health
Euroimmun offers a range of CE-marked ELISAs for determination of intrathecal antibodies in cerebrospinal fluid samples
Perform quantitative analyses of the biological nanoparticles and demonstrate properties for cellular communication and disease progression or inhibition
Experienced commercial leader to lead strategic expansion of Cresset's molecular modeling expertise and solutions
Harness exhaled breath for real-time monitoring of microbial metabolites and health impacts
Funds will aid in the completion of its upper respiratory panel multiplex on Co-Dx PCR Home platform
Innovative machine learning approach used to develop a tiny model capable of running on a satellite’s limited processing power
Elementar Americas explores the changing analytical requirements in the rapidly growing alternative protein industry
Fully automated testing and innovative features for premium clinical diagnostic solutions
Tailored process control solutions and expert support
AI-driven HART blood tests demonstrate high accuracy in diverse patient populations and beyond cardiac disease
High-throughput organs-on-chip platforms for disease research and drug discovery in neurology and dermatology
Exploring microbiome-directed therapies, precision medicine with big data, health equity, and more
Beckman Coulter Life Sciences offers tailored solutions for EU GMP compliance and beyond